AHL Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$13M Buy
161,548
+36,029
+29% +$2.89M 0.2% 105
2017
Q3
$9.76M Sell
125,519
-62,259
-33% -$5.17M 0.17% 171
2017
Q2
$16.7M Buy
187,778
+8,943
+5% +$754K 0.35% 12
2017
Q1
$14.4M Buy
178,835
+122,662
+218% +$9.58M 0.32% 14
2016
Q4
$4M Buy
56,173
+3
+0% +$236 0.12% 313
2016
Q3
$4.85M Sell
56,170
-5,441
-9% -$474K 0.18% 168
2016
Q2
$5.35M Buy
61,611
+47,172
+327% +$3.81M 0.29% 67
2016
Q1
$1.08M Buy
14,439
+8,060
+126% +$607K 0.07% 374
2015
Q4
$491K Sell
6,379
-6,662
-51% -$501K 0.04% 472
2015
Q3
$873K Buy
13,041
+8,047
+161% +$593K 0.14% 231
2015
Q2
$370K Sell
4,994
-83,629
-94% -$6.39M 0.01% 742
2015
Q1
$6.91M Buy
88,623
+13,239
+18% +$1M 0.28% 57
2014
Q4
$5.44M Sell
75,384
-13,013
-15% -$904K 0.28% 24
2014
Q3
$5.48M Buy
+88,397
New +$5.62M 0.42% 31

Other funds holding MDT

AHL Partners's MDT Position: Q4 2017 in Review

AHL Partners increased its Medtronic (MDT) stake by 29% in Q4 2017, buying an estimated $2.89M and bringing the position to 161,548 shares worth $13M. The position accounts for 0.2% of the portfolio, ranked #105.

AHL Partners first reported a position in MDT in Q3 2014 and has held it in 14 quarters since. The position peaked at $16.7M in Q2 2017. 1,408 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

  • AHL Partners held 161,548 shares of Medtronic worth $13M as of Q4 2017.
  • AHL Partners bought 36,029 Medtronic shares in Q4 2017, an estimated $2.89M.
  • Medtronic made up 0.2% of AHL Partners's portfolio in Q4 2017, its #105 holding.
  • AHL Partners first reported a position in Medtronic in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's Medtronic position peaked at $16.7M in Q2 2017.
  • 1,408 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.